PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 560.00
Bid: 562.00
Ask: 574.00
Change: 0.00 (0.00%)
Spread: 12.00 (2.135%)
Open: 560.00
High: 0.00
Low: 0.00
Prev. Close: 560.00
BMY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bloomsbury Acquires Oberon Books

10 Dec 2019 10:45

RNS Number : 3616W
Bloomsbury Publishing PLC
10 December 2019
 

10 December 2019

 

BLOOMSBURY PUBLISHING Plc

("Bloomsbury")

 

BLOOMSBURY ACQUIRES OBERON BOOKS

 

 

Bloomsbury Publishing Plc ("Bloomsbury") announces that it has today completed the acquisition of the entire issued share capital of Oberon Books Limited ("Oberon" or the "Acquisition"), the London-based drama publisher. The consideration was £1.2 million, all of which was satisfied in cash at completion. The business will operate within Bloomsbury's Academic & Professional division. Oberon generated £1.0 million* of revenue in the year ended 31 December 2018. There are opportunities for profit enhancements following the integration of the business into Bloomsbury. The Acquisition is expected to break even in its first year, before reorganisation and acquisition costs, then be earnings enhancing thereafter. It will contribute approximately £0.1 million of revenue to Bloomsbury in the year ending 28 February 2020. (*Unaudited)

 

This acquisition comes as Bloomsbury celebrates 60 years of Methuen Drama's Modern Plays, and the crowning of The Arden Shakespeare Third series, with the final play, Measure for Measure, publishing in January. The Oberon programme aligns perfectly with Bloomsbury's existing publishing, whilst strengthening its offerings in contemporary and cutting-edge theatre. With the combined lists of Oberon, Methuen Drama and The Arden Shakespeare, Bloomsbury is now the leading publisher in drama and the performing arts.

 

Jonathan Glasspool, Managing Director of Bloomsbury's Academic & Professional Division said:

"We are delighted to become owners of the prestigious Oberon list. The Oberon programme aligns very well with our existing publishing within Methuen Drama. The Oberon list strengthens our offerings in contemporary theatre. With the combined lists of Oberon, Methuen Drama and The Arden Shakespeare, Bloomsbury is looking forward to developing and diversifying its position as the world's leading international publisher in drama and the performing arts."

 

Oberon's founder James Hogan said:

"After 32 years it's time to ensure that Oberon and its authors achieve a secure, lively home in the future. I'm truly delighted that Bloomsbury, the leaders in drama publishing, are taking over to carry on the good work. I've spent nearly half of my life building Oberon's list and supporting new writers. It grew out of my work in a reading group at Riverside Studios in the early Eighties. I had little idea then that Oberon would flourish and become a major new force in the business. It's been a fantastic job working with so many brilliant authors and agents for so long."

 

-ENDS-

 

For further information, please contact:

Bloomsbury Publishing Plc

+44 (0) 20 7631 5630

Nigel Newton, Chief Executive

Penny Scott-Bayfield, Group Finance Director

Hudson Sandler

+44 (0) 20 7796 4133

Dan de Belder / Hattie Dreyfus

 

bloomsbury@hudsonsandler.com

 

NOTES TO EDITORS

 

Bloomsbury Publishing Plc

Bloomsbury Publishing Plc is a global independent publisher across trade, specialist, professional, school and higher education markets. Its Academic division has grown rapidly since its inception in 2008, publishing around 1200 titles per year and specialising in the arts, humanities and social sciences. It leads the field in innovative publishing, with a fast growing portfolio of digital resources, including the award-winning Drama Online.

 

The Methuen Drama imprint includes a diverse range of plays by authors including Sarah Kane, Katori Hall, Arthur Miller, Kwame Kwei-Armah, James Graham, Edward Bond, Lucy Prebble, Mark Ravenhill and Caryl Churchill. As well as play texts Methuen Drama publishes books for theatre-goers, students, scholars, practitioners, actors and those wishing to pursue a career in the theatre industry.

 

 

Oberon Books

Founded in 1985 by James Hogan, Oberon Books is now one of the most exciting publishers specialising in drama and the performing arts. It has a backlist of 1500+ books including some of the best of British theatre since the 1940s, diverse European and world theatre in translation and classics from the world's leading dramatists, and a wide range of publications covering the theatre, opera, dance, biography, performance studies, monologues, practical guides and fiction.

 

Oberon has a reputation for publishing some of the most challenging, exciting drama happening right now, bringing into print plays from the stages of the National Theatre, the Donmar Warehouse, the Royal Court, the Tricycle, Traverse, Soho, major regional theatres, and fringe theatres, not forgetting the West End and Broadway.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQCKKDQKBDDBBD
Date   Source Headline
28th Aug 20206:14 pmRNSDirector/PDMR Shareholding
28th Aug 20201:05 pmRNSTotal Voting Rights
25th Aug 20205:54 pmRNSFinal dividend: bonus issue of new shares
10th Aug 20205:04 pmRNSDirector/PDMR Shareholding
4th Aug 20207:00 amRNSDirector/PDMR Shareholding
31st Jul 20201:58 pmRNSFinal dividend: bonus issue of new shares
30th Jul 20205:54 pmRNSDirector/PDMR Shareholding
21st Jul 20201:00 pmRNSResults of the 2020 Annual General Meeting
21st Jul 20207:00 amRNSAGM Trading Update
8th Jul 20204:35 pmRNSAnnual General Meeting
18th Jun 20202:00 pmRNSAnnual Financial Report
17th Jun 202012:07 pmRNSSecond Price Monitoring Extn
17th Jun 202012:02 pmRNSPrice Monitoring Extension
12th Jun 20204:41 pmRNSSecond Price Monitoring Extn
12th Jun 20204:36 pmRNSPrice Monitoring Extension
3rd Jun 202012:08 pmRNSSecond Price Monitoring Extn
3rd Jun 202012:02 pmRNSPrice Monitoring Extension
26th May 20205:26 pmRNSBLOCK LISTING SIX MONTHLY RETURN
20th May 20207:00 amRNSUnaudited Preliminary Results
28th Apr 20203:37 pmRNSDisclosure of Rights Attached to Equity Shares
24th Apr 20209:10 amRNSHolding(s) in Company
24th Apr 20209:06 amRNSHolding(s) in Company
21st Apr 20208:45 amRNSTotal Voting Rights
20th Apr 202012:02 pmRNSPrice Monitoring Extension
17th Apr 202011:50 amRNSResult of Placing
17th Apr 20207:00 amRNSTrading and Dividend Update & Equity Placing
16th Apr 20204:41 pmRNSSecond Price Monitoring Extn
16th Apr 20204:35 pmRNSPrice Monitoring Extension
30th Mar 20204:42 pmRNSSecond Price Monitoring Extn
30th Mar 20204:36 pmRNSPrice Monitoring Extension
20th Mar 20207:00 amRNSBloomsbury Acquires Zed Books' Assets
19th Mar 20207:00 amRNSPre-close Trading Update
5th Feb 20205:39 pmRNSDirector Declaration
10th Dec 201910:45 amRNSBloomsbury Acquires Oberon Books
2nd Dec 20197:00 amRNSBLOOMSBURY ENTERS DOMESTIC CHINESE MARKET
25th Nov 20195:15 pmRNSBlock Listing Six Monthly Return
29th Oct 20197:00 amRNSUnaudited Interim Results
21st Oct 20196:18 pmRNSHolding(s) in Company
16th Oct 20195:58 pmRNSHolding(s) in Company
12th Sep 20195:29 pmRNSHolding(s) in Company
5th Sep 20193:37 pmRNSHolding(s) in Company
22nd Aug 20197:00 amRNSDirector/PDMR Shareholding
17th Jul 20194:19 pmRNSResults of the 2019 Annual General Meeting
17th Jul 20197:00 amRNSTrading Update
18th Jun 20198:21 amRNSAnnual Financial Report
7th Jun 201911:34 amRNSHolding(s) in Company
7th Jun 20197:00 amRNSHolding(s) in Company
31st May 20193:11 pmRNSDirector/PDMR Shareholding
24th May 20193:21 pmRNSBlock listing Interim Review
23rd May 201912:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.